Replication of genetic variation in the MYO9B gene in Crohn's disease

Human Immunology

Volumn 72, Issue 7, 2011, Pages 592-597

  Wolters, Victorien M ^a,b   Xu, Wei ^c,d   Zhao, Xingqiu ^e   Walters, Thomas D ^a   Griffiths, Anne M ^a   Silverberg, Mark S ^d   Muise, Aleixo M ^a,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Genetic susceptibility; Immunity; Inflammatory bowel disease; Intestinal permeability; MYO9B

Indexed keywords

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; ILEUM; MAGI2 GENE; MAJOR CLINICAL STUDY; MALE; MYO9B GENE; PARD3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

EID: 79958265603     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.03.025     Document Type: Article

References (47)

1. Hollander D., Vadheim C.M., Brettholz E., Petersen G.M., Delahunty T., Rotter J.I. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986, 105:883-885.
2. May G.R., Sutherland L.R., Meddings J.B. Is small intestinal permeability really increased in relatives of patients with Crohn's disease?. Gastroenterology 1993, 104:1627-1632.
3. Anderson C.A., Boucher G., Lees C.W., Franke A., D'Amato M., Taylor K.D., et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011, 43:246-252.
4. Picco P., Gattorno M., Marchese N., Vignola S., Sormani M.P., Barabino A., et al. Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters. Clin Exp Rheumatol 2000, 18:773-778.
5. Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol 2008, 24:701-706.
6. Meddings J. The significance of the gut barrier in disease. Gut 2008, 57:438-440.
7. Buhner S., Buning C., Genschel J., Kling K., Herrmann D., Dignass A., et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?. Gut 2006, 55:342-347.
8. Katz K.D., Hollander D., Vadheim C.M., McElree C., Delahunty T., Dadufalza V.D., et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989, 97:927-931.
9. Baumgart D.C., Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640.
10. Monsuur A.J., de Bakker P.I., Alizadeh B.Z., Zhernakova A., Bevova M.R., Strengman E., et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005, 37:1341-1344.
11. Persengiev S., Koeleman B.P., Downes K., Valdigem G., van der Slik A.R., Eerligh P., et al. Association analysis of myosin IXB and type 1 diabetes. Hum Immunol 2010, 71:598-601.
12. Santiago J.L., Martínez A., Núñez C., de la Calle H., Fernández-Arquero M., de la Concha E.G., et al. Association of MYO9B haplotype with type 1 diabetes. Hum Immunol 2008, 69:112-115.
13. Cooney R., Cummings J.R., Pathan S., Beckly J., Geremia A., Hancock L., et al. Association between genetic variants in myosin IXB and Crohn's disease. Inflamm Bowel Dis 2009, 15:1014-1021.
14. Latiano A., Palmieri O., Valvano M.R., D'Incà R., Caprilli R., Cucchiara S., et al. The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2008, 27:241-248.
15. Nunez C., Oliver J., Mendoza J.L., Gomez-Garcia M., Pinero A., Taxonera C., et al. MYO9B polymorphisms in patients with inflammatory bowel disease. Gut 2007, 56:1321-1322.
16. van Bodegraven A.A., Curley C.R., Hunt K.A., Monsuur A.J., Linskens R.K., Onnie C.M., et al. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 2006, 131:1768-1774.
17. Post P.L., Tyska M.J., O'Connell C.B., Johung K., Hayward A., Mooseker M.S. Myosin-IXb is a single-headed and processive motor. J Biol Chem 2002, 277:11679-11683.
18. Bruewer M., Hopkins A.M., Hobert M.E., Nusrat A., Madara J.L. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin. Am J Physiol Cell Physiol 2004, 287:C327-C335.
19. Matter K., Balda M.S. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003, 4:225-236.
20. Sapone A., de Magistris L., Pietzak M., Clemente M.G., Tripathi A., Cucca F., et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006, 55:1443-1449.
21. Wirth J.A., Jensen K.A., Post P.L., Bement W.M., Mooseker M.S. Human myosin-IXb, an unconventional myosin with a chimerin-like rho/rac GTPase-activating protein domain in its tail. J Cell Sci 1996, 109:653-661.
22. Müller R.T., Honnert U., Reinhard J., Bähler M. The rat myosin myr 5 is a GTPase-activating protein for Rho in vivo: essential role of arginine 1695. Mol Biol Cell 1997, 8:2039-2053.
23. Muise A.M., Walters T.D., Glowacka W.K., Griffiths A.M., Ngan B.Y., Lan H., et al. Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease. Gut 2009, 58:1121-1127.
24. Wapenaar M.C., Monsuur A.J., van Bodegraven A.A., Weersma R.K., Bevova M.R., Linskens R.K., et al. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 2008, 57:463-467.
25. Wu X., Hepner K., Castelino-Prabhu S., Do D., Kaye M.B., Yuan X.J., et al. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci U S A 2000, 97:4233-4238.
26. Izumi Y., Hirose T., Tamai Y., Hirai S., Nagashima Y., Fujimoto T., et al. An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J Cell Biol 1998, 143:95-106.
27. Persengiev S., Koeleman B.P., Downes K., Valdigem G., van der Slik A.R., Eerligh P., et al. Association analysis of myosin IXB and type 1 diabetes. Hum Immunol 2010, 71:598-601.
28. Silverberg M.S., Daly M.J., Moskovitz D.N., Rioux J.D., McLeod R.S., Cohen Z., et al. Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Gut 2001, 49:773-776.
29. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 2002, 347:417-429.
30. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(suppl A):5-36.
31. Terwilliger J.D. Handbook of human genetic linkage 1994, Johns Hopkins University Press, New York.
32. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
33. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
34. Freidlin B., Zheng G., Li Z., Gastwirth J.L. Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum Hered 2002, 53:146-152.
35. Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., McLeod R.S., Griffiths A.M., et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000, 66:1863-1870.
36. van Heel D.A., Dechairo B.M., Dawson G., McGovern D.P., Negoro K., Carey A.H., et al. The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants. Hum Mol Genet 2003, 12:2569-2575.
37. D'Inca R., Annese V., di Leo V., Latiano A., Quaino V., et al. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. Aliment Pharmacol Ther 2006, 23:1455-1461.
38. Concannon P., Chen W.M., Julier C., Morahan G., Akolkar B., Erlich H.A., et al. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes 2009, 58:1018-1022.
39. Arnott I.D., Nimmo E.R., Drummond H.E., Fennell J., Smith B.R., MacKinlay E., et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?. Genes Immun 2004, 5:417-425.
40. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
41. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
42. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007, 39:207-211.
43. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39:596-604.
44. Yamazaki K., McGovern D., Ragoussis J., Paolucci M., Butler H., Jewell D., et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005, 14:3499-3506.
45. Fasano A., Not T., Wang W., Uzzau S., Berti I., Tommasini A., et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000, 355:1518-1519.
46. Wang W., Uzzau S., Goldblum S.E., Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 2000, 113:4435-4440.
47. Post P.L., Bokoch G.M., Mooseker M.S. Human myosin-IXb is a mechanochemically active motor and a GAP for rho. J Cell Sci 1998, 111:941-950.